Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experience - PubMed (original) (raw)

Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experience

Lynn E Eberly et al. Diabetes Care. 2003 Mar.

Abstract

Objective: To report long-term risks for total, cardiovascular disease (CVD), and coronary heart disease (CHD) mortality associated with incident diabetes (using current diagnostic criteria) and with incident nonfatal CVD (NF-CVD).

Research design and methods: A total of 11645 participants without diabetes or CVD at baseline from the Multiple Risk Factor Intervention Trial who survived to the end of the trial were grouped by during-trial incident diabetes and/or NF-CVD events: neither diabetes nor NF-CVD, diabetes only, NF-CVD only, or both diabetes and NF-CVD. Incident diabetes was defined by use of hypoglycemic agents or fasting glucose >or=126 mg/dl at any time over the 6 trial years. Proportional hazards models tested group differences in mortality over 18 post-trial years.

Results: Among 3859 total deaths were 1846 from CVD and 1277 from CHD, with death rates per 10000 person-years of 203, 97, and 67, respectively. Multivariate-adjusted hazard ratios (HRs) for total mortality were 2.75 (P < 0.0001) for those with NF-CVD and diabetes both, 1.92 (P < 0.0001) for those with NF-CVD only, and 1.49 (P < 0.0001) for those with diabetes only, relative to neither diabetes nor NF-CVD. NF-CVD was associated with a higher hazard of death than diabetes for total (HR 1.29, P = 0.0004), CVD (HR 1.76, P < 0.0001), and CHD (HR 1.88, P < 0.0001) mortality. Only the subgroup of participants on hypoglycemic agents showed an equivalent risk of total mortality relative to participants with NF-CVD (HR 0.93, P = 0.54).

Conclusions: Current diabetes diagnostic criteria conferred significantly increased total, CVD, and CHD mortality risks independent of the impact of NF-CVD. NF-CVD was more strongly predictive of mortality.

PubMed Disclaimer

Cited by

Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: a Markov modelling study.
Ngalesoni FN, Ruhago GM, Mori AT, Robberstad B, Norheim OF. Ngalesoni FN, et al. BMC Health Serv Res. 2016 May 17;16:185. doi: 10.1186/s12913-016-1409-3. BMC Health Serv Res. 2016. PMID: 27184802 Free PMC article.
Obesidad y Esperanza de Vida en México Obesity and life expectancy in Mexico.
Monteverde M, Novak B. Monteverde M, et al. Poblac Salud Mesoam. 2008 Jul-Dec;6(1):4. Poblac Salud Mesoam. 2008. PMID: 25705173 Free PMC article.
Hypertension with metabolic syndrome: think thiazides are old hat? ALLHAT says think again.
Mendoza MD, Stevermer JJ. Mendoza MD, et al. J Fam Pract. 2008 May;57(5):306-10. J Fam Pract. 2008. PMID: 18460295 Free PMC article.
Mortality trends in subjects with and without diabetes during 33 years of follow-up.
Jansson SP, Andersson DK, Svärdsudd K. Jansson SP, et al. Diabetes Care. 2010 Mar;33(3):551-6. doi: 10.2337/dc09-0680. Epub 2009 Dec 15. Diabetes Care. 2010. PMID: 20009100 Free PMC article.
The Presence of Diabetes Mellitus or Pre-diabetes Mellitus Increases Mortality from Heart Disease in a Taiwanese Population: A 10-year Follow-Up Study.
Tsai HC, Hsu PS, Pan LF, Hung CL, Yang DH, Hung KC, Liao CC. Tsai HC, et al. BMC Cardiovasc Disord. 2023 Jul 28;23(1):375. doi: 10.1186/s12872-023-03406-5. BMC Cardiovasc Disord. 2023. PMID: 37507664 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information

Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experience - PubMed (original) (raw)